Varian Medical Systems Inc

Varian Medical Systems — Investor Presentation (December 2019)

14 slides from Varian Medical Systems's investor presentation, Dec 4, 2019

  1. Slide 1: Governance Update December 2019

    Slide 1: Governance Update December 2019

    Governance Update December 2019

  2. Slide 2: Focus driving strong operational execution since 2017

    Slide 2: Focus driving strong operational execution since 2017

    Focus driving strong operational execution since 2017 Confidence in our long - term strategy Note: Data as of FY2017, excluding Varex . * Comparison of FY19 to FY17 ** According to IMV ServiceTrak in U.S. Radiation Oncology Systems Report 8% 3Y Oncology Orders CAGR 8,500+ 9% * Linac Installed Base 4

  3. Slide 3: Long-term growth and value creation strategy

    Slide 3: Long-term growth and value creation strategy

    Long - term growth and value creation strategy 3 Surgical Oncology Medical Oncology & Immuno therapy Diagnosis RO Proton Software Equip Services Radiation Oncology Proton Equip Services Provider - Based Services Interventional Oncology Software Tech - Enabled Services ‘17 Horizon 1 Global Radiothera

  4. Slide 4: Comprehensive cancer care portfolio

    Slide 4: Comprehensive cancer care portfolio

    Comprehensive cancer care portfolio 4 ARIA ® Oncology Information System 360 Oncology ™ Care Management Platform Connectivity Epic, Cerner, ARIA Connect Halcyon ™ TrueBeam ® VitalBeam ™ Trilogy ® Clinac ® UNIQUE ™ Radiotherapy Systems ProBeam ® ProBeam ® 360 ° Proton Therapy Systems Calypso ® system

  5. Slide 5: Strong execution in FY19

    Slide 5: Strong execution in FY19

    Strong execution in FY19 Annual Revenues +10% $3,225 Million 1 Oncology systems gross orders. 2 GAAP to Non - GAAP reconciliation is disclosed in Varian’s fiscal year 2019 fourth quarter earnings press release and furnished to the Securities Exchange Commission (“SEC”) in a Form 8 - K on October 23,

  6. Slide 6: Executing on long-term growth strategy

    Slide 6: Executing on long-term growth strategy

    KEY METRICS • >5,500 software customers Unique software customers grew +8% in Q4 • >2,500 RapidPlan orders to date installed >1,800 licenses at 660 customer locations • 17 Ethos orders since ASTRO launch 11 new systems and 6 conversions in Europe and Australia KEY ACCOMPLISHMENTS • Noona patient - r

  7. Slide 7: New growth platforms

    Slide 7: New growth platforms

    New growth platforms 7 Interventional Solutions Platform Boston Scientific Beads Portfolio Cancer Treatment Services International Performing better than expected Brings Varian closer to the patient and provider to gain clinical data and insights Facilitates identification of unmet clinical needs to

  8. Slide 8: Commitment to corporate governance best practices

    Slide 8: Commitment to corporate governance best practices

    Commitment to corporate governance best practices 8 Majority voting for election of directors Declassified board Separate CEO and independent Chair roles 6 new independent directors in last 5 years 4 women on board, 40% gender diversity Proxy access bylaw FOR INVESTOR USE ONLY

  9. Slide 9: Varian's Board possesses deep and diverse expertise

    Slide 9: Varian's Board possesses deep and diverse expertise

    Varian’s Board possesses deep and diverse expertise 9 Powerful combined skillset, strongly aligned with the Company’s strategic objectives INDUSTRY KNOWLEDGE Contributes to a deeper understanding of healthcare trends and technologies and our business strategy, operations, key performance indicators

  10. Slide 10: 2019 CEO compensation program overview

    Slide 10: 2019 CEO compensation program overview

    13% 11% 46% 30% 2019 CEO compensation program overview 10 1 Other NEOs receive long - term equity granted in PSUs (60%), RSUs (20%) and Stock Options (20%) 2 Economic profit is referred to internally as Varian Value Added (VVA); see slide 11 for details regarding how we calculate VV A Base Salary At

  11. Slide 11: 2019 compensation program

    Slide 11: 2019 compensation program

    2019 compensation program We continued to leverage program changes made in 2018 that were designed to better align incentives with our growth strategy and best practices 11 Component 2019 Program Rationale Annual Cash Incentive Management Incentive Plan ► Economic Profit (80%, measured by VVA) ► Pre

  12. Slide 12: Sustainability at Varian

    Slide 12: Sustainability at Varian

    Sustainability at Varian 12 Extending access to quality healthcare, delivering safe and effective products, and having a beneficial impact on the communities where we operate • Our efforts focus on: − Operational Excellence: growing our business while reducing our environmental impact, maintaining h

  13. Slide 13: Sustainability at Varian: Operational and innovation highlights

    Slide 13: Sustainability at Varian: Operational and innovation highlights

    Sustainability at Varian Operational and innovation highlights 13 1 Improves access to quality care for millions of patients globally 2 Half the weight of a traditional machine 3 Uses half the energy of a traditional machine 4 Requires two thirds less concrete and is self - shielding 5 Uses less SF

  14. Slide 14: Our promise: People powering victories

    Slide 14: Our promise: People powering victories

    Our promise 14 People powering victories Imagine a world without fear of cancer. We do, every day. We innovate new technologies for treating cancer and for connecting clinical teams to advance patient outcomes. Through ingenuity we inspire new victories and empower people in the fight against cancer

Source: SEC EDGAR · 8-K filed Dec 4, 2019

More decks from Varian Medical Systems Inc